Search

Search Constraints

You searched for: Author/Creator Harris, Wayne B.

Search Results

1. Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. (2021)

2. Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. (8th July 2021)

3. Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. (5th December 2019)

4. Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. (18th August 2021)

5. Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. (8th July 2021)

6. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. (18th March 2021)

8. Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. (29th July 2012)

9. Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. (25th February 2020)